Anika Therapeutics, Inc. (ANIK)
NGS · Common · CUSIP 035255108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ANIK and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
035255108
Market Cap
Mid Cap · $857 Million
Business: Anika Therapeutics, Inc. headquartered in Bedford, Mass., develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Anika's products range from orthopedic/joint health solutions led by Orthovisc, a treatment for osteoarthritis of the knee; to surgical aids in the ophthalmic and anti-adhesion fields. The company also offers aesthetic dermal fillers for the correction of facial wrinkles. Anika's Italian subsidiary, Anika Therapeutics, S.r.l, provides complementary HA products in orthopedic/joint health and anti-adhesion, as well as therapeutics in new areas such as advanced wound treatment and ear, nose and throat care. Their regenerative tissue technology advances Anika's vision to offer therapeutic products that go beyond pain relief to protect and restore damaged tissue.

Company Contact

CEO
Joseph Darling
CFO
Sylvia Cheung
Headquarters
32 Wiggins Avenue, Bedford, MA 01730
Phone
781-457-9000
Fax
781-305-9720
Investor Relations
Sylvia Cheung · 781-457-9000 · investorrelations@anikatherapeutics.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »